rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Brenton Taylor

EVP, Operations & R&D

Company insider

Files Form 4 as: EVP, Operations & R&D, Sight Sciences; EVP, Engineering, Inogen.

In numbers

Trades disclosed
232
Buys
0
Sells
42
Bought
$0
Sold
$21.6M
Companies
2
Companies where not an officer
0
First trade
1 Apr 2014
Last trade
2 Oct 2026
Last filed
5 Oct 2026

Companies traded

Where they are an officer
SGHT Sight SciencesOfficer · Medical Devices · last 2 Oct 20260 buys · 6 sells
INGN InogenOfficer · Medical Devices · last 28 Sep 20210 buys · 36 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
2 Oct 2026filed 5 Oct 2026SGHT Sight SciencesMedical DevicesSEC FORM 4 Sold$26K2,988 at $8.85filing
1 Jul 2026filed 6 Jul 2026SGHT Sight SciencesMedical DevicesSEC FORM 4 Sold$15K2,829 at $5.42filing
1 Jul 2026filed 6 Jul 2026SGHT Sight SciencesMedical DevicesSEC FORM 4 Sold$15K2,829 at $5.42filing
1 Apr 2026filed 3 Apr 2026SGHT Sight SciencesMedical DevicesSEC FORM 4 Sold$11K2,869 at $3.70filing
1 Apr 2026filed 3 Apr 2026SGHT Sight SciencesMedical DevicesSEC FORM 4 Sold$11K2,869 at $3.70filing
3 Feb 2026filed 5 Feb 2026SGHT Sight SciencesMedical DevicesSEC FORM 4 Code A—100,464 at $0.00filing
3 Feb 2026filed 5 Feb 2026SGHT Sight SciencesMedical DevicesSEC FORM 4 Code A—100,464 at $0.00filing
6 Jan 2026filed 6 Jan 2026SGHT Sight SciencesMedical DevicesSEC FORM 4 Sold$4,630619 at $7.48filing
6 Jan 2026filed 6 Jan 2026SGHT Sight SciencesMedical DevicesSEC FORM 4 Sold$4,630619 at $7.48filing
17 Nov 2025filed 18 Nov 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Sold$102K14,418 at $7.06filing
6 Oct 2025filed 8 Oct 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Sold$1,992591 at $3.37filing
2 Sep 2025filed 3 Sep 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Code A—25,840 at $0.00filing
12 Nov 2024filed 18 Nov 2024SGHT Sight SciencesMedical DevicesSEC FORM 4 Code A$734K160,000 at $4.59filing
28 Sep 2021filed 30 Sep 2021INGN Inogenoption or derivative · Medical DevicesSEC FORM 4 Code M—12,945 at $0.00filing
28 Sep 2021filed 30 Sep 2021INGN InogenMedical DevicesSEC FORM 4 Code M$10K12,945 at $0.81filing
1 Sep 2021filed 3 Sep 2021INGN Inogenoption or derivative · Medical DevicesSEC FORM 4 Code M—273 at $0.00filing
1 Sep 2021filed 3 Sep 2021INGN InogenMedical DevicesSEC FORM 4 Code M—273 at $0.00filing
1 Sep 2021filed 3 Sep 2021INGN InogenMedical DevicesSEC FORM 4 Code F$21K345 at $60.57filing
27 Jul 2021filed 29 Jul 2021INGN InogenMedical DevicesSEC FORM 4 Code M$306K7,942 at $38.54filing
27 Jul 2021filed 29 Jul 2021INGN InogenMedical DevicesSEC FORM 4 Sold$596K7,942 at $75.02filing

News

Insider Selling: Sight Sciences (NASDAQ:SGHT) CTO Sells $70,562.85 in StockSGHT · themarketsdaily.com · 8 Oct 2026Financial Contrast: Nano-X Imaging (NASDAQ:NNOX) & Sight Sciences (NASDAQ:SGHT)SGHT · themarketsdaily.com · 8 Oct 2026

0 headlines in the last 90 days name Brenton Taylor; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care42

Buys in green, sells in red, by the company’s sector.

Related people

Alison BauerleinChief Operating Officer · Chief Operating Officer at Sight Sciences, filing Form 4 there in the last year
David BadawiChief Technology Officer · Chief Technology Officer at Sight Sciences, filing Form 4 there in the last year
Paul BadawiPresident and CEO · President and CEO at Sight Sciences, filing Form 4 there in the last year
James RodbergChief Financial Officer · Chief Financial Officer at Sight Sciences, filing Form 4 there in the last year
Kevin Raymond Merrill SmithCEO and President · CEO and President at Inogen, filing Form 4 there in the last year